U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415824) titled 'Multiple Sclerosis Implementation Network (Registry)' on Jan. 29.
Brief Summary: The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with ...